bm
Bristol Myers Squibb
BMY
NYSE $62.42
Does Bristol Myers Squibb have high-quality management?
CEO Chris Boerner, formerly Chief Commercialization Officer and COO, became CEO in November 2023 and Board Chair in April 2024. His tenure has emphasized productivity and BD execution while advancing launches such as Cobenfy and Opdivo Qvantig.
Leadership has communicated a multiyear cost‑savings plan and a focus on growth in the back half of the decade, but the period will test portfolio execution amid LOEs.
Read the full report on Bristol Myers Squibb and explore the other sections
Overview of Bristol Myers Squibb
Does Bristol Myers Squibb have a strong competitive moat?
Does Bristol Myers Squibb have pricing power in its industry?
How predictable is Bristol Myers Squibb's business?
Is Bristol Myers Squibb financially strong?
How effective is Bristol Myers Squibb's capital allocation strategy?
Does Bristol Myers Squibb have high-quality management?
What is the fair value of Bristol Myers Squibb stock?